Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact
Login Book a demo
Glytec logo — The only provider of insulin management software across the...

Glytec

The only provider of insulin management software across the full continuum of care, from hospital to home.

Founded 2006 United States Greenville, United States 75 employees Venture round Total: $41.97M Health Care, Health and Wellness

General Information

Company Name Glytec
Founded Year 2006
Location United States Greenville, United States
Employees 75
Industries Health Care, Health and Wellness
Funding Stage Venture round
Social

BounceWatch is an independent company data service, not affiliated with Glytec. To contact Glytec, visit glytecsystems.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Glytec compare?

A PDF of Glytec and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Glytec soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Glytec

Glytec, The only provider of insulin management software across the full continuum of care, from hospital to home, is a healthcare-focused startup established in 2006. The company is headquartered in the United States and has recently secured a $9.00M Debt Financing investment from Silicon Valley Bank in April 2021. Glytec's FDA-cleared titration software and proprietary algorithms offer personalized diabetes treatment recommendations from hospital to home. The company's team, comprising doctors, nurses, and technologists, is committed to enhancing patient outcomes and mitigating costs for a diverse population requiring insulin treatment, including individuals with or without a diabetes diagnosis. Glytec's innovative approach and focus on improving the quality and cost of care positions it as a notable player within the Health Care industry. For more information, interested parties can follow Glytec on X (@Glytec) or visit www.GlytecSystems.com.

Business keywords: insulin management software, diabetes treatment, digital therapeutics, FDA-cleared, clinical decision support, medication optimization, health information technology, populational health, digital health, patient safety, value-based care, medical device, medication management, healthcare optimization

Funding Rounds & Investors (9)

View All
Funding Stage Amount Investors Lead Investors Date
Venture Round $12.00M 1
Savitr Capital
Savitr Capital
26 Apr 2021
Debt Financing $9.00M 1
Silicon Valley Bank
26 Apr 2021
Venture Round $2.97M -
13 Nov 2013
Venture Round $3.50M -
15 Jul 2013
Venture Round $4.00M -
16 Nov 2012
Series A $8.27M 2
Standard Pacific Capital Holdings
Standard Pacific Capital Holdings, Sea Dragon Healthcare Partners
19 Sep 2011
Debt Financing $2.00M -
09 Jun 2011
Venture Round $100.00K -
13 Jan 2011
Seed Round $131.42K -
13 Jul 2009

Glytec Alternatives & Competitors

View All Alternatives
Glytec vs
DEARhealth
DEARhealth The Netherlands

DEARhealth biedt dynamische en risicogebaseerde zorgpaden en slimme beslissingsondersteuning voor me...

Acquired
9 employees
Health Care, Health and Wellness
Glytec vs
GenXys
GenXys Canada

Digital Health Tech leader with pharmacogenetics expertise providing excellent medication decision s...

Seed
18 employees
Digital Health, Enterprise Software
Glytec vs
Stēto
Stēto France

Creating continuous care in diabetes

Seed
12 employees
Health Care, Health and Wellness
Also compare with: Glytec vs Diagnosoft, Inc. Diagnosoft, Inc. View all alternatives

FAQ About Glytec

The only provider of insulin management software across the full continuum of care, from hospital to home.
Glytec was founded in 2006.
Glytec is headquartered in Greenville, United States.
Glytec operates in Health Care and Health and Wellness. Its work centres on insulin management software, diabetes treatment, digital therapeutics and FDA-cleared.
Glytec has approximately 75 employees.
Glytec has completed 9 funding rounds, raising a total of $41.97M. The latest funding stage is Venture round.
Top alternatives and competitors to Glytec include DEARhealth, GenXys, Stēto, Injurymap, mySugr. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Glytec and DEARhealth are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Glytec, https://bouncewatch.com/company/glytec, updated 27 October 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes